A Real World Data of Ocrelizumab in Multiple Sclerosis

被引：0
|
作者：
Beckmann, Y.
Uzunkopru, C.
机构：
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1240
引用
收藏
页码：671 / 671
页数：1
相关论文
共 50 条
  • [41] Real world data on treatment of pediatric onset multiple sclerosis
    Neuteboom, Rinze
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 45 : A1 - A1
  • [42] Safety and Efficacy of Ocrelizumab in Multiple Sclerosis - a Real Clinical Sitting in Kuwait
    Alroughani, R.
    Jasem, A.
    AlMojel, M.
    Ahmed, S. Farouk
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 98 - 98
  • [43] Ocrelizumab: A Review in Multiple Sclerosis
    Syed, Yahiya Y.
    CNS DRUGS, 2018, 32 (09) : 883 - 890
  • [44] Ocrelizumab in pediatric multiple sclerosis
    Amirov, Ceren Bibinoglu
    Saltik, Sema
    Yalcinkaya, Cengiz
    Tutuncu, Melih
    Saip, Sabahattin
    Siva, Aksel
    Uygunoglu, Ugur
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 43 : 1 - 5
  • [45] Real-world safety data from up to 4.5 years of ocrelizumab in relapsing and primary progressive multiple sclerosis - a CONFIDENCE interim analysis
    Weber, Martin
    Buttmann, Mathias
    Meuth, Sven
    Bluemich, Sandra
    Dirks, Petra
    Eggebrecht, Julius
    Hieke-Schulz, Stefanie
    Leemhuis, Jost
    Ziemssen, Tjalf
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 373 - 374
  • [46] Ocrelizumab for the treatment of multiple sclerosis
    Bigaut, Kevin
    De Seze, Jerome
    Collongues, Nicolas
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (02) : 97 - 108
  • [47] Ocrelizumab: A Review in Multiple Sclerosis
    Lamb, Yvette N.
    DRUGS, 2022, 82 (03) : 323 - 334
  • [48] Ocrelizumab: A Review in Multiple Sclerosis
    Yvette N. Lamb
    Drugs, 2022, 82 : 323 - 334
  • [49] Ocrelizumab: A Review in Multiple Sclerosis
    Yahiya Y. Syed
    CNS Drugs, 2018, 32 : 883 - 890
  • [50] Autologous hematopoietic stem cells transplantation vs Alemtuzumab and Ocrelizumab in Multiple Sclerosis: a real-world comparison
    Zito, Antonio
    Signori, Alessio
    Sormani, Maria Pia
    Polidoro, Federica
    Nicholas, Richard
    Muraro, Paolo
    Scalfari, Antonio
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 53 - 53
12345